{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:18:29Z","timestamp":1769750309606,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Lorestan University (Lorestan, Iran) for this investigation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejphar.2020.173011","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T11:20:55Z","timestamp":1581679255000},"page":"173011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["In vitro investigation of the effect of mesalazine on amyloid fibril formation of hen egg-white lysozyme and defibrillation lysozyme fibrils"],"prefix":"10.1016","volume":"874","author":[{"given":"Masoumeh","family":"Faramarzian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seifollah","family":"Bahramikia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Dehghan Shasaltaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173011_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.saa.2019.02.004","article-title":"A quercetin-based flavanoid (rutin) reverses amyloid fibrillation in \u03b2-lactoglobulin at pH\u00a02.0 and 358\u00a0K","volume":"214","author":"Al-Shabib","year":"2019","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejphar.2020.173011_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1529\/biophysj.104.048819","article-title":"Thermally induced fibrillar aggregation of hen egg white lysozyme","volume":"88","author":"Arnaudov","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2020.173011_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1747-0285.2012.01391.x","article-title":"Syntheses and structure \u2013 activity relationships of seven manganese \u2013 salen derivatives as anti-amyloidogenic and fibril-destabilizing agents against hen egg-white lysozyme aggregation","volume":"80","author":"Bahramikia","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejphar.2020.173011_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijbiomac.2011.10.018","article-title":"Anti-amyloidogenic and fibril-destabilizing effects of two manganese-salen derivatives against hen egg-white lysozyme aggregation","volume":"50","author":"Bahramikia","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2020.173011_bib5","first-page":"57","article-title":"Thermal aggregation of hen egg white lysozyme\u00a0: effect of polyamines Thermal aggregation of hen egg white lysozyme\u00a0: effect of polyamines","volume":"4","author":"Bi","year":"2014","journal-title":"J. Paramed. Sci."},{"key":"10.1016\/j.ejphar.2020.173011_bib6","first-page":"1052","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"385","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.ejphar.2020.173011_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1073\/pnas.222681699","article-title":"Amyloid-protein (A) assembly: a40 and A42 oligomerize through distinct pathways","volume":"100","author":"Bitan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2020.173011_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/cb1001203","article-title":"ANS binding reveals common features of cytotoxic amyloid species","volume":"5","author":"Bolognesi","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejphar.2020.173011_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejphar.2020.173011_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejphar.2020.173011_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","article-title":"Protein misfolding, evolution and disease","volume":"24","author":"Dobson","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2020.173011_bib12","series-title":"Innovative Concepts in Inflammatory Bowel Diseases","first-page":"276","author":"Emmrich","year":"1999"},{"key":"10.1016\/j.ejphar.2020.173011_bib13","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/j.febslet.2012.09.037","article-title":"Inhibition of amyloid fibrillation of lysozyme by phenolic compounds involves quinoprotein formation","volume":"586","author":"Feng","year":"2012","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.ejphar.2020.173011_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jmb.2006.06.055","article-title":"Identification of the core structure of lysozyme amyloid fibrils by proteolysis","volume":"361","author":"Frare","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2020.173011_bib15","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2020.173011_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejphar.2020.173011_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12154-009-0027-5","article-title":"Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status","volume":"3","author":"Groenning","year":"2010","journal-title":"J. Chem. Biol."},{"key":"10.1016\/j.ejphar.2020.173011_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.ejphar.2020.173011_bib19","first-page":"1","article-title":"A new era for understanding amyloid structures and disease","volume":"20","author":"Iadanza","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173011_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-230X-14-159","article-title":"A new family with hereditary lysozyme amyloidosis with gastritis and inflammatory bowel disease as prevailing symptoms","volume":"14","author":"Jean","year":"2014","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ejphar.2020.173011_bib21","article-title":"Pre-micellar concentrations of sodium dodecylbenzene sulfate induce amyloid-like fibril formation in myoglobin at pH 4.5","volume":"124240","author":"Khan","year":"2019","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ejphar.2020.173011_bib22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0006-3495(03)74550-0","article-title":"A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy","volume":"85","author":"Khurana","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2020.173011_bib23","article-title":"6-CM-H2DCFDA | C27H19Cl3O8 - PubChem","year":"2016","journal-title":"PubChem. Compd. Database"},{"key":"10.1016\/j.ejphar.2020.173011_bib24","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1074\/jbc.M608207200","article-title":"Small molecule inhibitors of aggregation indicate that amyloid\u00a0\u03b2 oligomerization and fibrillization pathways are independent and distinct","volume":"282","author":"Necula","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173011_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","article-title":"Techniques to study amyloid fibril formation in vitro","volume":"34","author":"Nilsson","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2020.173011_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1098\/rstb.2000.0766","article-title":"Pathogenesis, diagnosis and treatment of systemic amyloidosis","volume":"356","author":"Pepys","year":"2001","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.ejphar.2020.173011_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/362553a0","article-title":"Human lysozyme gene mutations cause hereditary systemic amyloidosis","volume":"362","author":"Pepys","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173011_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejphar.2020.173011_bib29","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1021\/bi00483a007","article-title":"1H NMR studies of human lysozyme: spectral assignment and comparison with hen lysozyme","volume":"29","author":"Redfield","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2020.173011_bib30","series-title":"Drug Delivery: Handbook of Experimental Pharmacology","first-page":"378","author":"Sch\u00e4fer-Korting","year":"2009"},{"key":"10.1016\/j.ejphar.2020.173011_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189754","article-title":"Unraveling the novel effects of aroma from small molecules in preventing hen egg white lysozyme amyloid fibril formation","volume":"13","author":"Seraj","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173011_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pKa prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejphar.2020.173011_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1994.tb00001.x","article-title":"Amyloidosis","volume":"25","author":"Tan","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.ejphar.2020.173011_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT\u00a0: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ejphar.2020.173011_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4292\/wjgpt.v6.i4.137","article-title":"Mesalazine preparations for the treatment of ulcerative colitis: are all created equal?","volume":"6","author":"Ye","year":"2015","journal-title":"World J. Gastrointest. Pharmacol. Therapeut"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920301035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920301035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:07:23Z","timestamp":1762142843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920301035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":35,"alternative-id":["S0014299920301035"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173011","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro investigation of the effect of mesalazine on amyloid fibril formation of hen egg-white lysozyme and defibrillation lysozyme fibrils","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173011"}}